Redesign Health

www.redesignhealth.com

VCMatch tracks Redesign Health as an investor focused on AI/ML, Digital Health, and Healthtech companies and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Not specified

Focus Areas

AI/ML, Digital Health, Healthtech

Geography

Global

Investment Thesis

Redesign Health frames its investment philosophy as redesigning healthcare by applying advanced technologies—especially AI—at a systems level. They emphasize a systems view of healthcare (rules, incentives, capital flows) and treat venture as an “AI-native” repeated, experimental, computational game where technical leverage, institutional relationships, and long-term patient value drive company building and value creation.

Is Redesign Health right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Redesign Health is most relevant for founders raising venture-backed rounds in AI/ML, Digital Health, and Healthtech, especially across Global.

Focus statement

They focus on "building next-generation healthcare companies" at the intersection of healthcare and artificial intelligence, partnering with founders and existing businesses through "AI-native venture capital and buyout strategies."

Value Add

Operates as an AI-native company itself: "Redesign operates as the same kind of AI-native company we back, with experimentation at the core and technical leverage in every function."
Proprietary AI infrastructure: an "AI knowledge graph built on millions of hours of internal expert research and hundreds of thousands of relationships with institutions and decision makers."
Integrated platform model: described as a "global venture and applied technology platform" that deploys domain expertise, institutional relationships, and a commercial/technical apparatus alongside portfolio teams.
Dual investment approach: explicit use of both venture capital and buyout strategies: "AI-native venture capital and buyout strategies."
Proven operational scale and outcomes: since 2018 the firm and portfolio companies "have touched the lives of more than 15 million patients and raised over $1.5 billion."